IBUPROFEN BRANDS' DOUBLE-DIGIT SALES GROWTH IN 1992
This article was originally published in The Tan Sheet
IBUPROFEN BRANDS' DOUBLE-DIGIT SALES GROWTH IN 1992 in both food and drug outlets represented the fastest-growing segment in the OTC analgesic marketplace, according to a report from Information Resources' subsidiary Towne-Oller. The 1992 year-end report, entitled "Highlights & Trends of Health & Beauty Care in Food Stores and Drug Stores," notes that ibuprofen sales grew 12% last year in food stores versus 2% growth for all OTC analgesics, and increased 10% in drug stores compared to 5% for all analgesics. Ibuprofen products captured 24.1% of analgesic sales in retail food outlets in 1992, which represented a $ 1.3 bil. market. The sales increase translated into a gain of 2.2 share points over 1991. Ibuprofen's share of drug store OTC analgesic sales increased one market share point to 22.6% of the just over $ 1 bil. market, according to Towne-Oller. Based on the data in the report, ibuprofen-containing OTC analgesics generated combined food and drug store sales of approximately $ 545 mil. in 1992, netting roughly 23.4% of the $ 2.32 bil. analgesic market. Acetaminophen-containing analgesics lost some market share in food stores to ibuprofen products but increased market share in drug stores. The Towne-Oller data show that acetaminophen sales grew 7% in drug stores last year, increasing market share by .9 percentage points to 45.4%. In food stores, acetaminophen analgesic sales grew 2% with market share slipping to 47.3%, from 47.5% in 1991. The market share figures translate to over $ 450 mil. in drug store sales for acetaminophen products and about $ 620 mil. in food store sales last year. Nearly all of the ibuprofen market share gain was at the expense of aspirin-based analgesics and aspirin compounds. In food stores, aspirin compound sales declined 5% in 1992 and market share declined from a year-earlier 19.6% to 18.2%. Aspirin sales declined 3% in food stores with market share falling one half of a percentage point to 10.4%. In drug stores, aspirin sales grew 4% last year; however, market share edged down slightly to 15.5%, from 15.7% in 1991. Those figures translate into drug store sales of about $ 150 mil. and food store sales of $ 137 mil. in 1992. Analgesics continue to be the leading OTC/H&BA category sold in both food and drug stores, according to Towne-Oller. The total 1992 U.S. health and beauty care dollar volume was projected to be $ 13.3 bil. in food stores and $ 13.5 bil. in drug stores. Anti-gas products are one of the fastest growing segments in the antacid market, according to the Towne-Oller data. Sales for products marketed as antiflatulents increased by 42% in food stores and 13% in drug stores in 1992. Antiflatulents share of the $ 395.5 mil. food store antacid market was 5.7%, up 1.5 percentage points, while share in the $ 372.8 mil. drug store market was 12.8%, up one share point. In addition, drug store sales of antacids with simethicone grew 20% in 1992 and commanded a 12.7% share of the $ 372.8 mil. market, up 1.7 share points from 1991. Sales of simethicone- containing antacids grew more slowly in food stores -- increasing 15% to about $ 45 mil. and an 11.3% market share. Enzyme-based antacid sales grew 55% in food stores and garnered a 4.5% market share (up from 3% in 1991); the products increased 21% in drug stores, earning a 9.9% market share (up from 8.5%). Sales of OTC antacids grew 4% in 1992 in both food and drug store outlets to about $ 770 mil. combined. Sales of antidiarrheals -- a smaller, but faster growing market measured in dollars -- grew 21% in food stores to $ 65.3 mil. and 15% in drug stores to $ 78.1 mil., according to Towne-Oller. Caplets are the fastest growing dosage form segment, increasing sales by 44% in food stores and 34% in drug stores last year, and hold a 53.1% share of the food store market and 54.4% share of the drug store market. Baking soda dentifrices dollar volume rose 69% in 1992, making the segment one of the health and beauty care top dollar gainers in food and drug stores combined, Towne-Oller reported. Baking soda dentifrices accounted for 14.3% of the overall dentifrice 1992 sales of $ 835.5 mil. in food stores, or about $ 120 mil. In drug stores, the baking soda category captured a 16.1% share (or approximately $ 50 mil.) of projected 1992 dentifrice sales of $ 310.6 mil. Sales of baking soda dentifrices grew 61% in food stores and 93% in drug stores in 1992. Whiteners, another category in the dentifrices segment, was one of the top gainers in dollar share in both food and drug stores. The category leaped 301% in food stores, generating 1.7% (or about $ 14.2 mil.) of the dentifrices segment projected volume, and climbed 42% in drug stores to 9.8% (or $ 30.4 mil.) of projected volume. Desensitizing products also gained dollar share in both food and drug stores, up 7% and 17% in sales, respectively. Baking soda dentifrices, whiteners and desensitizing products gained dollar share from traditional dentifrices and traditional anti-stain products, which posted decreases in dollar share in food and drug stores in 1992. Traditional dentifrices, accounting for the majority of volume in the dentifrices segment, was down 4% in food stores and 2% in drug stores. A smaller category, traditional anti-stain products, dropped 19% and 15% in food and drug stores, respectively. Sunscreens with SPFs of 16 and higher recorded dollar share gains of 15% and 21% in food and drug stores, respectively, accounting for half of the overall sunscreens segment projected 1992 volume of $ 66.2 mil. in food stores and $ 90.7 mil. in drug stores. SPF 15 sunscreens dropped 6% in food stores but gained 2% in dollar share in drug stores. The category holds about a third of the sunscreens segment dollar share. The smallest category in the segment, sunscreens with SPFs ranging from 5 to 14, was flat in food stores but rose 17% in drug stores.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Sign in to continue reading.
Need a specific report?
1000+ reports available
New to Pink Sheet?
Start a free trial today!
Register for our free email digests: